Abstract:The frequent immune escape of tumor cells and fluctuating therapeutic efficiency vary with each individual are two critical issues for immunotherapy against malignant tumor. Herein, we fabricated an intelligent core-shell nanoparticle (SNAs@CCMR) to significantly inhibit the PD-1/PD-L1 mediated immune escape by on-demand regulation of various oncogenic microRNAs and perform RNAs dependent photothermal-immunotherapy to achieve precise and efficient treatment meeting the individual requirements of specific patients by in situ generation of customized tumor-associated antigens. The SNAs@CCMR consisted of antisense oligonucleotides grafted gold nanoparticles (SNAs) as core and TLR7 agonist imiquimod (R837) functionalized cancer cell membrane (CCM) as shell, in which the acid-labile Schiff base bond was used to connect the R837 and CCM. During therapy, the acid environment of tumor tissue cleaved the Schiff base to generate free R837 and SNAs@CCM. The SNAs@CCM further entered tumor cells via CCM mediated internalization, and then specifically hybridized with over-expressed miR-130a and miR-21, resulting in effective inhibition of the migration and PD-L1 expression of tumor cells to avoid their immune escape. Meanwhile, the RNAs capture also caused significant aggregation of SNAs, which immediately generated photothermal agents within tumor cells to perform highly selective photothermal therapy under NIR irradiation. These chain processes not only damaged the primary tumor, but also produced plenty of tumor-associated antigens, which matured the surrounding dendritic cells (DCs) and activated anti-tumor T cells along with the released R837, resulting in the enhanced immunotherapy with suppressive immune escape. Both in vivo and in vitro experiments demonstrated that our nanoparticles were able to inhibit primary tumor and its metastasis via multi-regulation of carcinogenic microRNAs and RNAs dependent photothermal-immune activations, which provided a promising strategy to reprogram the immunosuppressive microenvironment in tumor tissue for better malignant tumor therapy.

In Vivo Monocyte/Macrophage-hitchhiked Intratumoral Accumula-tion of Nanomedicines for Enhanced Tumor Therapy.

Gold Nanocage-Based Photothermal Ablation Facilitates in Situ Vaccination for Melanoma Therapy.

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Antibody-activated Trans-Endothelial Delivery of Mesoporous Organosilica Nanomedicine Augments Tumor Extravasation and Anti-Cancer Immunotherapy

Tumor Microenvironment-Activatable Nanosystem Capable of Overcoming Multiple Therapeutic Obstacles for Augmenting Immuno/Metal-Ion Therapy.

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.

On-demand Reprogramming of Immunosuppressive Microenvironment in Tumor Tissue Via Multi-Regulation of Carcinogenic Micrornas and RNAs Dependent Photothermal-Immunotherapy Using Engineered Gold Nanoparticles for Malignant Tumor Treatment

Vascular Bursts-Mediated Tumor Accumulation and Deep Penetration of Spherical Nucleic Acids for Synergistic Radio-Immunotherapy.

Macrophages As an Active Tumour-Targeting Carrier of SN38-nanoparticles for Cancer Therapy

Self-oriented Central-Tumor Delivery of Legumain-Cleavable Vehicles Governed by Circulating Monocyte/macrophage for Precise Tumor Enrichment and Immune Activation

A Homologous-Targeting "nanoconverter" with Variable Size for Deep Tumor Penetration and Immunotherapy.

Nanomedicine engulfed by macrophages for targeted tumor therapy

A Novel Strategy Through Combining Irgd Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.

Nanoreactors with Cascade Catalytic Activity Reprogram the Tumor Microenvironment for Enhanced Immunotherapy by Synchronously Regulating Treg and Macrophage Cells

Multifunctional Nanocapsules on a Seesaw Balancing Sonodynamic and Photodynamic Therapies Against Superficial Malignant Tumors by Effective Immune-Enhancement.

Nano-engineered Lymphocytes for Alleviating Suppressive Tumor Immune Microenvironment

A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation.

Inhibiting Solid Tumor Growth in Vivo by Non-Tumor-Penetrating Nanomedicine

Designing Gold-Seaurchin-Based Nano-Immunomodulator to Remodel Tumor Microenvironment <i>Via</i> Photothermal Intervention and αCD16 Gene Expression for Boosting NK Cell Adoptive Immunotherapy